In this Healio Video Perspective from the Retina World Congress, Dilraj S. Grewal, MD, FASRS, provides an update on the progress of therapies for noninfectious uveitis. While some therapies failed ...

YUTIQ addresses a significant unmet need in the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The uveitis treatment market is projected to grow steadily ...

DelveInsight's "YUTIQ Market Size, Forecast, and Market Insight Report" highlights the details around YUTIQ, a sterile ...

Infectious uveitis can result from a bacterium or a virus in your eye. Test your vision to see if your eyesight has changed Measure the pressure in your eye Widen, or dilate, your pupils so they ...

VivaVision Biotech reveals promising phase 2 trial results for VVN461, a new treatment for Non-Infectious Anterior Uveitis, ...

subjects treated with prednisolone acetate (p <0.001). Note: ACC (anterior chamber cells) were evaluated using SUN grading scale. Both VVN461 dose groups demonstrated statistically significant and ...

a potent dual JAK1/TYK2 inhibitor for the treatment of Non-Infectious Anterior Uveitis (NIAU) in China. Both 0.5% and 1% of VVN461 ophthalmic solutions showed non-inferior efficacy compared to ...

Uveitis recurrence was defined as an increase in the anterior chamber cell grade, vitreous haze, or the emergence of new active inflammatory chorioretinal or retinal lesions in one or both eyes ...